Origin of transferable cefotaxime resistance in a clinical isolate of Escherichia coli by mutation.

doi:10.1080/1120009x.1994.11741122

Back to search

Article

Origin of transferable cefotaxime resistance in a clinical isolate of Escherichia coli by mutation.

Journal of chemotherapy (Florence, Italy) - 1 Feb 1994

Králiková K, Krcméry V, Hupková M, Blahova J

Abstract excerpt

A clinical isolate of Escherichia coli susceptible to cefotaxime and ceftazidime from a polytraumatic pediatric patient, transferred a series of determinants of resistance to antibiotics, including cephalotin-cefazolin, to a recipient strain of E. coli K-12. When cephalotin-resistant clones of K-...

Topics

Cefotaxime
Ceftazidime
Conjugation, Genetic
Drug Resistance, Microbial
Escherichia coli
Microbial Sensitivity Tests
Mutation

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.